The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1

Laboratory Investigation

Volumn 88, Issue 1, 2008, Pages 78-88

  Butler, Samantha L ^a   Dong, Huijia ^a   Cardona, Diana ^a   Jia, Minghong ^a   Zheng, Ran ^a   Zhu, Haizhen ^a   Crawford, James M ^a   Liu, Chen ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

CPS1; Hep Par 1 antibody; Liver; Liver cancer; Urea cycle

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE; DNA; HEP PAR 1 ANTIBODY; MONOCLONAL ANTIBODY; RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METASTASIS; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UREA CYCLE;

EID: 37549050204     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700699     Document Type: Article

References (36)

1. Minervini MI, Demetris AJ, Lee RG, et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 1997;10:686-692.
2. Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol 1993;143:1050-1054.
3. Lamps LW, Folpe AL. The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review. Adv Anat Pathol 2003;10:39-43.
4. Zimmerman RL, Burke MA, Young NA, et al. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver. Cancer 2001;93:288-291.
5. Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol 2002;26:978-988.
6. Fasano M, Theise ND, Nalesnik M, et al. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anticarcinoembryonic antigen. Mod Pathol 1998;11:934-938.
7. Hall LM, Johnson RC, Cohen PP. The presence of carbamyl phosphate synthetase in intestinal mucosa. Biochim Biophys Acta 1960;37:144-145.
8. Maitra A, Murakata LA, Albores-Saavedra J. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol 2001;115:689-694.
9. Lugli A, Tornillo L, Mirlacher M, et al. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. Am J Clin Pathol 2004;122:721-727.
10. Kakar S, Muir T, Murphy LM, et al. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Am J Clin Pathol 2003;119:361-366.
11. Trompetas V, Varsamidakis N, Frangia K, et al. Gastric hepatoid adenocarcinoma and familial investigation: does it always produce alpha-fetoprotein? Eur J Gastroenterol Hepatol 2003;15:1241-1244.
12. Fan Z, van de Rijn M, Montgomery K, et al. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol 2003;16:137-144.
13. Villari D, Caruso R, Grosso M, et al. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study. Pathology 2002;34:423-426.
14. Zhang J, Parwani AV, Ali SZ. Hepatocyte paraffin 1 immunoexpression in esophageal brush samples. Cancer 2005;105:304-309.
15. Zhu H, Dong H, Eksioglu E, et al. Hepatitis C virus trigger apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterolgy 2007;133:1649-1659.
16. Shang XZ, Zhu H, Lin K, et al. Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis. Lab Invest 2004;84:332-341.
17. Zhu H, Zhao H, Collins CD, et al. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 2003;37:1180-1188.
18. Zhu H, Nelson DR, Crawford JM, et al. Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance. J Interferon Cytokine Res 2005;25:528-539.
19. LeCluyse EL, Alexandre E, Hamilton GA, et al. Isolation and culture of primary human hepatocytes. Methods Mol Biol 2005;290:207-229.
20. Chu PG, Jiang Z, Weiss LM. Hepatocyte antigen as a marker of intestinal metaplasia. Am J Surg Pathol 2003;27:952-959.
21. Metzenberg RL, Marshall M, Cohen PP. Purification of carbamyl phosphate synthetase from frog liver. J Biol Chem 1958;233:102-105.
22. Jones ME. Amino acid metabolism. Annu Rev Biochem 1965;34:381-418.
23. Nyunoya H, Broglie KE, Widgren EE, Lusty CJ. Characterization and derivation of the gene coding for mitochondrial carbamyl phosphate synthetase I of rat. J Biol Chem 1985;260:9346-9356.
24. Adcock MW, O'Brien WE. Molecular cloning of cDNA for rat and human carbamyl phosphate synthetase I. J Biol Chem 1984;259:13471-13476.
25. Tillman JB, Dhahbi JM, Mote PL, et al. Dietary calorie restriction in mice induces carbamyl phosphate synthetase I gene transcription tissue specifically. J Biol Chem 1996;271:3500-3506.
26. Gupta S, Rogers LK, Taylor SK, et al. Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice. Toxicol Appl Pharmacol 1997;146:317-327.
27. Gelehrter TD, Snodgrass PJ. Lethal neonatal deficiency of carbamyl phosphate synthetase. N Engl J Med 1974;290:430-433.
28. Badizadegan K, Perez-Atayde AR. Focal glycogenosis of the liver in disorders of ureagenesis: its occurrence and diagnostic significance. Hepatology 1997;26:365-373.
29. Struck J, Uhlein M, Morgenthaler NG, et al. Release of the mitochondrial enzyme carbamoyl phosphate synthase under septic conditions. Shock 2005;23:533-538.
30. Crouser ED, Julian MW, Huff JE, et al. Carbamoyl phosphate synthase-1: a marker of mitochondrial damage and depletion in the liver during sepsis. Crit Care Med 2006;34:2439-2446.
31. Wu G. Urea synthesis in enterocytes of developing pigs. Biochem J 1995;312(Part 3):717-723.
32. Davis PK, Wu G. Compartmentation and kinetics of urea cycle enzymes in porcine enterocytes. Comp Biochem Physiol B Biochem Mol Biol 1998;119:527-537.
33. Moonen RM, Paulussen AD, Souren NY, et al. Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis. Pediatr Res 2007;62:188-190.
34. Kumagai I, Masuda T, Sato S, et al. Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histological pattern. Hepatol Res 2001;20:312-319.
35. Sugiki T, Yamamoto M, Aruga A, et al. Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody hepatocyte paraffin 1. J Surg Oncol 2004;88:104-107.
36. Kinoshita M, Miyata M. Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci. Hepatology 2002;36:433-438.